Found 15 matching trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
PHASE3This study is designed to evaluate the efficacy and safety of tofacitinib (...
Location
Internal Medicine Center, LLC
Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan
PHASE3The purpose of this study is to determine the long-term effectiveness and s...
Location
National hospital Organization Nagoya Medical Center
Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient
PHASE2A new immunosuppressive drug, based on the inhibition of an important enzym...
Location
Multi Organ Transplant Center
Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550
PHASE2All patients will be in instructed to eat a therapeutic lifestyle diet and ...
Location
Pfizer Investigational Site
Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function
PHASE1A study to evaluate the pharmacokinetics of CP-690,550 in subjects with mil...
Location
Pfizer Investigational Site
Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy Volunteers
PHASE1Estimate the effect of oral ketoconazole administration (400 mg once daily ...
Location
Pfizer Investigational Site
A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.
PHASE2The hypothesis of the study is that at least one dose of CP 690 550 is supe...
Location
Pfizer Investigational Site
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
PHASE3The study proposes to assess whether compared to placebo, CP-690,550 is eff...
Location
Internal Medicine Center, LLC
Pharmacokinetics And Safety Study Of Two CP-690,550 Controlled Release Formulation Following Single Dose In Healthy Volunteers
PHASE1This study will explore the drug behavior and safety following single dose ...
Location
Pfizer Investigational Site
Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis
PHASE1The purpose of study is to explore the effect of CP-690,550 (tasocitinib) o...
Location
Pfizer Investigational Site